BioMark Diagnostics Financial Overview
BioMark Diagnostics's market cap is currently C$46.24M. The company's EPS TTM is C$-0.005; its P/E ratio is -27.16; BioMark Diagnostics is scheduled to report earnings on November 29, 2025, and the estimated EPS forecast is C$―. See an overview of income statement, balance sheet, and cash flow financials.
